CATALAYER NEWS
J&J files for FDA approval of $6.5B autoimmune drug, teeing up showdown with argenx and UCB - Fierce Biotech
Source: Fierce Biotech · 2024-08-29
Full article text is available in the Catalayer news terminal.
RELATED ON CATALAYER
Related Topics
Biotech & FDA NewsRELATED MARKETS
Prediction Markets